An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction

Haylen, Bernard T.; Ridder, Dirk De; Freeman, Robert; Swift, Steven; Berghmans, Bary; Lee, Joseph; Monga, Ash; Petri, E.; Rizk, Diaa E. E.; Sand, Peter K.; Schaer, Gabriel N.

doi:10.1002/nau.20798

Cited by 2,142 publications

(1,066 citation statements)

References 41 publications

Supporting

Mentioning

1,022

Contrasting

Unclassified

Order By: Relevance

“…Women taking hormone replacement therapy were admissible as long as their prescriptions had been stable for at least 6 months. Women were excluded if they were unable to understand either French or English; had chronic constipation (per the Rome III criteria) [15]; pelvic organ prolapse (POP) ≥2 according to the POP Quantification system [16]; were taking medications known to affect continence; had mobility, medical, or psychological problems that would prevent them from completing the assessments or the exercise program [17,18]; and/or had a condition or implant that contraindicated MRI scanning. The secondary analysis received ethical approval from the institutional ethics committee and from the ethics committees at each of the participating hospitals.…”

Section: Participantsmentioning

confidence: 99%

Changes in urethral sphincter size following rehabilitation in older women with stress urinary incontinence

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Participantsmentioning

confidence: 99%

Changes in urethral sphincter size following rehabilitation in older women with stress urinary incontinence

et al. 2014

View full text Add to dashboard Cite

show abstract

“…PN is defined by burning vaginal or vulval pain (anywhere between the anus and the clitoris) associated with tenderness over the course of the pudendal nerve 1. PN due to pudendal nerve entrapment (PNE) is related to loss of mobility of the pudendal nerve over its gluteal or pelvic course.…”

Section: Introductionmentioning

confidence: 99%

Adding corticosteroids to the pudendal nerve block for pudendal neuralgia: a randomised, double‐blind, controlled trial

Riant

Lassaux

et al. 2016

BJOG

View full text Add to dashboard Cite

ObjectiveTo compare the effect of corticosteroids combined with local anaesthetic versus local anaesthetic alone during infiltrations of the pudendal nerve for pudendal nerve entrapment.DesignRandomised, double‐blind, controlled trial.SettingMulticentre study.Population201 patients were included in the study, with a subgroup of 122 women.Methods CT‐guided pudendal nerve infiltrations were performed in the sacrospinous ligament and Alcock's canal. There were three study arms: patients in Arm A (n = 68) had local anaesthetic alone, those in Arm B (n = 66) had local anaesthetic plus corticosteroid and those in Arm C (n = 67) local anaesthetic plus corticosteroid with a large volume of normal saline.Main outcome measuresThe primary end‐point was the pain intensity score at 3 months. Patients were regarded as responders (at least a 30‐point improvement on a 100‐point visual analogue scale of mean maximum pain over a 2‐week period) or nonresponders.ResultsThree months’ postinfiltration, 11.8% of patients in the local anaesthetic only arm (Arm A) were responders versus 14.3% in the local anaesthetic plus corticosteroid arms (Arms B and C). This difference was not statistically significant (P = 0.62). No statistically significant difference was observed in the female subgroup between Arm A and Arms B and C (P = 0.09). No significant difference was detected for the various pain assessment procedures, functional criteria or quality‐of‐life criteria.ConclusionsCorticosteroids provide no additional therapeutic benefits compared with local anaesthetic and should therefore no longer be used.Tweetable abstractSteroid infiltrations do not improve the results of local anaesthetic infiltrations in pudendal neuralgia.

show abstract

“…Urodynamic evaluation demonstrated a neurogenic acontractile detrusor function as defined by the International Continence Society [9]. Over the years he frequently suffered from UTIs, M a n u s c r i p t with predominant complains of dysuria and lower abdominal pain.…”

Section: Casementioning

confidence: 95%

“…Urodynamic evaluation demonstrated a neurogenic acontractile detrusor function that was ascribed to diabetic neuropathy [9]. She started to perform CIC four to six times daily.…”

Section: Casementioning

confidence: 99%

Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation

Nieuwkoop

Exter

Elzevier

et al. 2010

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Clean intermittent catheterisation (CIC) of the bladder is used to imitate normal bladder emptying in patients with bladder dysfunction. CIC is associated with urinary tract infection (UTI) that may be difficult to treat in the case of antimicrobial resistance. The aim of this study was to establish the effect and safety of intravesical gentamicin treatment in such settings. In 2009, intravesical gentamicin treatment was started in selected patients. Here we describe our experience with two patients treated until March 2010. Two patients using CIC suffering recurrent UTI with multiresistant Escherichia coli were treated with daily administration of 80 mg intravesical gentamicin. On treatment they appeared asymptomatic. During 8-and 9-month follow-up they were free of UTI, urine cultures were negative and there were no side effects. A systematic review was conducted through searches of PubMed and other databases. Clinical trials that met the eligibility criteria and displayed the efficacy or safety of intravesical aminoglycoside treatment in patients using CIC were studied. Study selection was performed by two independent reviewers. Eight studies were included for review. Owing to study heterogeneity, a meta-analysis could not be performed. Of four controlled studies using neomycin or kanamycin, two demonstrated a significant reduction in bacteriuria, whilst two other trials did not. One case series on neomycin/polymyxin showed that the majority of patients still developed bacteriuria. Three case series using gentamicin all pointed towards a significant reduction in bacteriuria and UTIs. There were no clinically relevant side effects reported but follow-up in all studies was limited. Although data are limited, intravesical treatment with gentamicin might be a reasonable treatment option in selected patients practicing CIC who suffer recurrent UTIs with highly resistant microorganisms.

show abstract

An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction

Abstract: A consensus-based terminology report for female pelvic floor dysfunction has been produced aimed at being a significant aid to clinical practice and a stimulus for research.

Cited by 2,142 publications

References 41 publications

Changes in urethral sphincter size following rehabilitation in older women with stress urinary incontinence

Changes in urethral sphincter size following rehabilitation in older women with stress urinary incontinence

Adding corticosteroids to the pudendal nerve block for pudendal neuralgia: a randomised, double‐blind, controlled trial

Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation

Contact Info

Product

Resources

About